Protease resistant insulin analogues

Details for Australian Patent Application No. 2007298919 (hide)

Owner Novo Nordisk A/S

Inventors Havelund, Svend; Hubalek, Frantisek; Balschmidt, Per; Lautrup-Larsen, Inger; Ribel-Madsen, Ulla; Norgaard, Per; Ludvigsen, Svend; Nielsen, Peter Kresten

Agent Shelston IP

Pub. Number AU-A-2007298919

PCT Pub. Number WO2008/034881

Priority 06121113.2 22.09.06 EP

Filing date 20 September 2007

Wipo publication date 27 March 2008

International Classifications

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

C12N 15/17 (2006.01) Mutation or genetic engineering

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/034881 Priority application(s): WO2008/034881

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007298920-Fluorinated catharanthine derivatives, their preparation and their utilisation as Vinca dimeric alkaloid precursors

2007298913-Method and apparatus for liquefying a hydrocarbon stream